1: Zamora A, Masana L, Civeira F, Ibarretxe D, Fanlo-Maresma M, Vila A, Suárez
Tembra M, Marco-Benedí V, Alvarez-Sala-Walther LA, Camacho-Ruiz M. Prognostic
stratification of familial hypercholesterolaemia patients using AI algorithms: a
gender-specific approach. Eur Heart J Digit Health. 2025 Aug 26;6(6):1113-1123.
doi: 10.1093/ehjdh/ztaf092. PMID: 41267838; PMCID: PMC12629648.

2: Llop D, Paredes S, Ibarretxe D, Rosales R, Masana L, Ribalta J, Vallvé JC.
Atherosclerotic cardiovascular disease and mortality in a cohort of patients
with rheumatoid arthritis: a prospective study investigating microRNAs as
predictors of atherosclerosis and mortality. Front Immunol. 2025 Oct
8;16:1667553. doi: 10.3389/fimmu.2025.1667553. PMID: 41132650; PMCID:
PMC12540091.

3: Tajes M, Ras-Jiménez MDM, Girona J, Ramos-Polo R, Guardiola M, García-Pinilla
JM, Ribalta J, Cobo-Marcos M, Masana L, de Juan-Bagudá J, Fonseca C, Enjuanes C,
Vázquez-Carrera M, Comin-Colet J, Rodríguez-Calvo R. Serum Growth
Differentiation Factor 15 (GDF15) Levels Reflect Ischemic Etiology in Heart
Failure Patients with Iron Deficiency: A Cross-Sectional Study. Biomolecules.
2025 Aug 26;15(9):1234. doi: 10.3390/biom15091234. PMID: 41008541; PMCID:
PMC12467985.

4: Amigó N, Torné P, Nordestgaard LT, Di Giacomo-Barbagallo F, Merino C, Magni
P, González-Lleó A, Andreychuk N, Catapano AL, Masana L, Ibarretxe D.
Triglycerides as Determinants of Global Lipoprotein Derangement: Implications
for Cardiovascular Prevention. Int J Mol Sci. 2025 Aug 26;26(17):8284. doi:
10.3390/ijms26178284. PMID: 40943205; PMCID: PMC12427746.

5: González-Lleó AM, Brito-Casillas Y, Martín-Santana V, Gil-Quintana Y, Tugores
A, Scicali R, Riaño M, Hernández-Baraza L, Jiménez-Monzón R, Girona J, Di
Giacomo Barbagallo F, Masana L, Boronat M, Wägner AM, Sánchez-Hernández RM.
Glucose metabolism in heterozygous familial hypercholesterolemia with a founder
effect and a high diabetes prevalence: a cross-sectional study. Cardiovasc
Diabetol. 2025 Aug 6;24(1):322. doi: 10.1186/s12933-025-02857-8. PMID: 40770647;
PMCID: PMC12330011.

6: Nordestgaard LT, Wolford BN, de Gonzalo-Calvo D, Sopić M, Devaux Y, Matic L,
Wettinger SB, Schmid JA, Amigó N, Masana L, Catapano AL, Kardassis D, Magni P;
EU-AtheroNET COST Action CA21153. Multiomics in atherosclerotic cardiovascular
disease. Atherosclerosis. 2025 Sep;408:120414. doi:
10.1016/j.atherosclerosis.2025.120414. Epub 2025 Jun 26. PMID: 40663987.

7: Masana L, Torné P, Garcia-Moll X, Dalli E, Amigó N; “Xarxa de Unitats de
Lípids i Arteriosclerosis of Catalonia”. Widespread lipoprotein alterations in a
REDUCE-IT like population: The icosapent ethyl (IPE)-NMR avatar study. Nutr
Metab Cardiovasc Dis. 2025 Nov;35(11):104199. doi: 10.1016/j.numecd.2025.104199.
Epub 2025 Jun 18. PMID: 40651885.

8: Roger G, Packard CJ, Masana L, Laufs U, Catapano AL, Steg PG. Concept and
practice in the use of high-dose eicosapentaenoic acid for cardiovascular
disease prevention in hypertriglyceridaemia. Heart. 2025 May
10:heartjnl-2025-325765. doi: 10.1136/heartjnl-2025-325765. Epub ahead of print.
PMID: 40348413.

9: Di Giacomo Barbagallo F, Bosco G, Di Marco M, Scilletta S, Miano N, Musmeci
M, Martedì M, González-Lleó AM, Ibarretxe D, De Francesco EM, Malaguarnera R, Di
Pino A, Masana L, Purrello F, Piro S, Scicali R. Evaluation of glycemic status
and subclinical atherosclerosis in familial hypercholesterolemia subjects with
or without LDL receptor mutation. Cardiovasc Diabetol. 2025 Mar 20;24(1):126.
doi: 10.1186/s12933-025-02683-y. PMID: 40114220; PMCID: PMC11927314.

10: Girona J, Guardiola M, Barroso E, García-Altares M, Ibarretxe D, Plana N,
Ribalta J, Amigó N, Correig X, Vázquez-Carrera M, Masana L, Rodríguez-Calvo R.
GDF15 Circulating Levels Are Associated with Metabolic-Associated Liver Injury
and Atherosclerotic Cardiovascular Disease. Int J Mol Sci. 2025 Feb
26;26(5):2039. doi: 10.3390/ijms26052039. PMID: 40076667; PMCID: PMC11900571.